A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis
- Ji Hyeon Kim
- , Soeun Park
- , Eunsun Jung
- , Jinwoo Shin
- , Yoon Jae Kim*
- , Ji Young Kim*
- , Jonathan L. Sessler*
- , Jae Hong Seo*
- , Jong Seung Kim*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
43
Link opens in a new tab
Citations
(Scopus)